Layoffs Stoke Concerns Around Potential Rise in HIV Infections, Medical Costs

  • Apr 10, 2025

    Directed by the new head of HHS, Robert F. Kennedy Jr., various federal health care agencies recently began implementing sweeping layoffs with the goal of eliminating about 10,000 positions. It’s difficult to understand exactly what the extent of the ramifications will be, but infectious diseases, including HIV and hepatitis, are among the hardest hit areas.

    According to the HIV+Hepatitis Policy Institute, layoffs included the entire staff of the HHS Office of Infectious Diseases & HIV Policy and the HHS Office of Minority Health, the policy and data division supporting the Health Resources & Services Administration’s Ryan White HIV/AIDS Program and hundreds of employees at HRSA’s Bureau of Primary Health Care.

    Read more
    © 2024 MMIT
  • Angela Maas

    Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. She also has written for Spotlight on Market Access since its 2017 launch. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at Hem Aware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×